Bruton's tyrosine kinase: oncotarget in myeloma
Copyright policy )Bruton's tyrosine kinase: oncotarget in myeloma
Our findings therefore provide a strong rationale for investigating Btk inhibitors in MM and WM to target both tumor cells and their supporting BM microenvironment and thereby both suppress tumor cell growth and abrogate MM-induced bone disease.
Adenine, Cell Growth Processes, Protein-Tyrosine Kinases, Disease Models, Animal, Mice, Pyrimidines, Piperidines, Agammaglobulinaemia Tyrosine Kinase, Animals, Humans, Pyrazoles, Molecular Targeted Therapy, Waldenstrom Macroglobulinemia, Multiple Myeloma
Adenine, Cell Growth Processes, Protein-Tyrosine Kinases, Disease Models, Animal, Mice, Pyrimidines, Piperidines, Agammaglobulinaemia Tyrosine Kinase, Animals, Humans, Pyrazoles, Molecular Targeted Therapy, Waldenstrom Macroglobulinemia, Multiple Myeloma
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).24 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!